Literature DB >> 19027629

Breast cancer in Mexico: a pressing priority.

Felicia Marie Knaul1, Gustavo Nigenda, Rafael Lozano, Hector Arreola-Ornelas, Ana Langer, Julio Frenk.   

Abstract

Breast cancer is a serious threat to the health of women globally, and an unrecognised priority in middle-income countries. This paper presents data from Mexico. It shows that breast cancer accounts for more deaths than cervical cancer since 2006. It is the second cause of death for women aged 30-54 and affects all socio-economic groups. Data on detection, although under-reported, show 6,000 new cases in 1990, and a projected increase to over 16,500 per year by 2020. Further, the majority of cases are self-detected and only 10% of all cases are detected in stage one. Mexico's social security systems cover approximately 40-45% of the population, and include breast cancer treatment. As of 2007, the rest of the population has the right to breast cancer treatment through the Popular Health Insurance. Despite these entitlements, services are lacking and interventions for early detection, particularly mammography, are very limited. As of 2006 only 22% of women aged 40-69 reported having a mammogram in the past year. Barriers exist on both the demand and supply sides. Lobbying, education, awareness-building and an articulated policy response will be important to ensure expanded coverage, access to and take-up of both treatment and early detection.

Entities:  

Mesh:

Year:  2008        PMID: 19027629     DOI: 10.1016/S0968-8080(08)32414-8

Source DB:  PubMed          Journal:  Reprod Health Matters        ISSN: 0968-8080


  25 in total

1.  Thymopoietin Beta and Gamma Isoforms as a Potential Diagnostic Molecular Marker for Breast Cancer: Preliminary Data.

Authors:  Daniel Marrero-Rodríguez; Keiko Taniguchi-Ponciano; Julio Lopez-Sleman; Pablo Romero-Morelos; Monica Mendoza-Rodríguez; Israel Garcia; Victor Huerta-Padilla; Alejandra Mantilla; Armando Duarte; Patricia Piña; Miriam Rodriguez-Esquivel; Ricardo Lopez-Romero; Jorge Parrazal-Romero; Salvador Tobias-Alonso; Florinda Jimenez-Vega; Mario Alvarez-Blanco; Mauricio Salcedo
Journal:  Pathol Oncol Res       Date:  2015-04-04       Impact factor: 3.201

2.  Evaluation of breast cancer knowledge among health promoters in Mexico before and after focused training.

Authors:  Nancy L Keating; Elena M Kouri; Héctor Arreola Ornelas; Oscar Méndez; Laura Magaña Valladares; Felicia Marie Knaul
Journal:  Oncologist       Date:  2014-09-17

3.  Recurrent BRCA1 and BRCA2 mutations in Mexican women with breast cancer.

Authors:  Gabriela Torres-Mejía; Robert Royer; Marcia Llacuachaqui; Mohammad R Akbari; Anna R Giuliano; Louis Martínez-Matsushita; Angélica Angeles-Llerenas; Carolina Ortega-Olvera; Elad Ziv; Eduardo Lazcano-Ponce; Catherine M Phelan; Steven A Narod
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11-04       Impact factor: 4.254

4.  Breast cancer knowledge, attitudes, and early detection practices in United States-Mexico border Latinas.

Authors:  Matthew P Banegas; Yelena Bird; John Moraros; Sasha King; Surasri Prapsiri; Beti Thompson
Journal:  J Womens Health (Larchmt)       Date:  2011-10-04       Impact factor: 2.681

5.  Alcohol and risk of breast cancer in Mexican women.

Authors:  Jeannette M Beasley; Gloria D Coronado; Jennifer Livaudais; Angélica Angeles-Llerenas; Carolina Ortega-Olvera; Isabelle Romieu; Eduardo Lazcano-Ponce; Gabriela Torres-Mejía
Journal:  Cancer Causes Control       Date:  2010-02-13       Impact factor: 2.506

6.  The impact of family history of breast cancer on knowledge, attitudes, and early detection practices of Mexican women along the Mexico-US border.

Authors:  Yelena Bird; Matthew P Banegas; John Moraros; Sasha King; Surasri Prapasiri; Beti Thompson
Journal:  J Immigr Minor Health       Date:  2011-10

7.  The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer.

Authors:  C Villarreal-Garza; J N Weitzel; M Llacuachaqui; E Sifuentes; M C Magallanes-Hoyos; L Gallardo; R M Alvarez-Gómez; J Herzog; D Castillo; R Royer; Mohammad Akbari; F Lara-Medina; L A Herrera; A Mohar; S A Narod
Journal:  Breast Cancer Res Treat       Date:  2015-02-26       Impact factor: 4.872

8.  HOXD13 methylation status is a prognostic indicator in breast cancer.

Authors:  Zhenbin Zhong; Ming Shan; Ji Wang; Tong Liu; Bingshu Xia; Ming Niu; Yanlv Ren; Da Pang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

9.  Prevalence and Determinants of Repeat Mammography Among Women from a Developing Country.

Authors:  Ana María Salinas-Martínez; Jimena Estefanía Gaspar-Rivera; Oscar Juárez-Pérez; José Roberto Montañez-Sauceda; Georgina Mayela Núñez-Rocha; Francisco Javier Guzmán-de-la-Garza; Álvaro Mathiew-Quirós
Journal:  J Community Health       Date:  2017-04

10.  Why the time is right to tackle breast and cervical cancer in low-resource settings.

Authors:  Vivien Davis Tsu; Jose Jeronimo; Benjamin O Anderson
Journal:  Bull World Health Organ       Date:  2013-09-01       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.